Mesoblast Limited (AU:MSB) has released an update.
Mesoblast Limited has announced that Dr. Eric Rose, a director of the company, has increased his indirect interest in the firm through the on-market purchase of 21,428 American Depositary Shares (ADS), each representing 10 ordinary shares, for a total consideration of US$142,318.35. Following this transaction, Dr. Rose’s holdings include 4,330,765 options and the mentioned ADSs, with an additional 5,039,814 ordinary shares to be potentially issued subject to shareholder approval at the upcoming 2024 Annual General Meeting.
For further insights into AU:MSB stock, check out TipRanks’ Stock Analysis page.
